Our ITO platform, datasets, and pipeline are available through flexible partnering modelsto accelerate R&D.

We've built the most powerful and fully integrated AI-driven drug discovery and development platform to enable significant cost and time savings for biotech and pharmaceutical companies.

ITO™ Platform

Partnering Model

Horizontal ITO™ Infrastructure

Horizontal ITO Infrastructure

Available Now

1910 will work with you to embed our full ITO™ Platform within your organization and customize it to solve your most pressing problems in drug discovery.

Co-Engineering

Co-Engineering

Available Now

Collaborate with 1910 at the level of data, AI models, optimized compute and interactive tools (e.g., dashboards, conversational chatbots) to engineer bespoke small or large molecule discovery modules that you can use in your organization.

Co-Discovery

Co-Discovery

Available Now

1910 will collaborate with you to leverage our ITO™ platform to design, manufacture, test, and deliver a small or large molecule drug candidate 
meeting your specifications.

Platform-as-a-
Service (PaaS)

Platform-as-a-Service

In Development

Directly access software modules from the 1910 Model Foundry™ that are part of our small and large molecule drug discovery platform.

Asset Licensing

Asset Licensing

Available Now

Lead compounds discovered by 1910 are licensed to strategic partners for further development.

Data Licensing

Data Licensing

Available Now

License high quality, multimodal, molecular, disease-relevant patient (genotypic and phenotypic) data to fill data gaps and build Al models for molecular design and novel target ID.

Deliverable

The 1910 ITO™ Platform

Bespoke AI
Models

Custom
Data

Therapeutics

Data Package

Interactive
Tools

DD LLM
Chatbots

Small
Molecules

Large
Molecules

Multiomic  
Data

Phenotypic & Molecular Data

Phenotypic
& Molec...

Phenotypic & Molecular Data

- EHR data
- Omics data
- Disease, relevant patient tissue data

Partners

Pharma

Biotech

VCs & Lab
Incubators

Academia

Government

Horizontal ITO Infrastructure

Available Now

We will work with you to embed our full ITO™ Platform within your organization and customize it to solve your largest drug discovery problems.

Co-Engineering

Available Now

Collaborate with us at the level of data, AI models, optimized compute and interactive tools (e.g., dashboards, chatbots) to engineer bespoke small or large molecule discovery modules that you can use in your organization.

Co-Discovery

Available Now

We will collaborate with you to leverage our ITO™ platform to design, manufacture, test, and deliver a small or large molecule drug candidate 
meeting your specifications.

Platform-as-a-Service

In Development

Directly access software modules from our Model Foundry™ that are part of our small and large molecule drug discovery platform.

Asset Licensing

Available Now

We identify and license lead compounds to strategic partners for therapeutic development.

Data Licensing

Available Now

License high quality, multimodal, molecular, disease-relevant patient (genotypic and phenotypic) data to fill data gaps and build Al models for molecular design and novel target ID.

Partner With 1910
Achieve The Full Potential of AI

Partner with us

Partner with us

Fill out the form to explore how we can work together.

Company

First Name

Last Name

Email

Phone

Message

Submit Message

Submit Message

Company

First Name

Last Name

Email

Phone

Message

Sumbit Message

Sumbit Message

Oops! Something went wrong while submitting the form.

Message sent successfully

Thanks for reaching out. Our team has received your message and will be in touch shortly.

Or if you prefer, you can contact us directly at

bd@1910.ai

Copy to clipboard

This website uses cookies to ensure you get the best experience.

This website uses 
cookies
 to ensure you
get the best experience.

Accept cookies

Accept cookies